March Altus Capital Management LP - Q3 2016 holdings

$16 Million is the total value of March Altus Capital Management LP's 11 reported holdings in Q3 2016. The portfolio turnover from Q2 2016 to Q3 2016 was 62.5% .

 Value Shares↓ Weighting
EW BuyEDWARDS LIFESCIENCES CORP$4,173,000
+124.8%
34,611
+86.0%
26.11%
+82.0%
ACAD SellACADIA PHARMACEUTICALS INC$2,313,000
-13.9%
72,723
-12.1%
14.47%
-30.3%
PETX  ARATANA THERAPEUTICS INC$2,045,000
+48.1%
218,5150.0%12.79%
+19.9%
JNJ  JOHNSON & JOHNSON$1,536,000
-2.6%
13,0000.0%9.61%
-21.2%
DXCM BuyDEXCOM INC$1,245,000
+34.2%
14,200
+21.4%
7.79%
+8.6%
LLY SellLILLY ELI & CO$1,068,000
-49.4%
13,310
-50.4%
6.68%
-59.1%
TSRO NewTESARO INC$1,002,00010,000
+100.0%
6.27%
ZTS NewZOETIS INCcl a$827,00015,900
+100.0%
5.17%
BIIB NewBIOGEN INC$814,0002,600
+100.0%
5.09%
ALXN SellALEXION PHARMACEUTICALS INC$760,000
-24.3%
6,199
-27.9%
4.76%
-38.7%
REGN NewREGENERON PHARMACEUTICALS$201,000500
+100.0%
1.26%
ALGN ExitALIGN TECHNOLOGY INC$0-17,319
-100.0%
-10.78%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2016-11-07
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
DEXCOM INC12Q3 201614.4%
LILLY ELI & CO12Q3 201620.0%
ALEXION PHARMACEUTICALS INC11Q3 201615.1%
MALLINCKRODT PUB LTD CO8Q3 20157.0%
UNITED THERAPEUTICS CORP DEL7Q3 201511.7%
REGENERON PHARMACEUTICALS7Q3 201614.6%
UNIVERSAL HLTH SVCS INC7Q2 201512.1%
ZOETIS INC7Q3 20165.2%
INCYTE CORP6Q4 201514.7%
EDWARDS LIFESCIENCES CORP5Q3 201628.5%

View March Altus Capital Management LP's complete holdings history.

Latest filings
TypeFiled
13F-HR2016-11-07
13F-HR2016-07-27
13F-HR2016-05-12
13F-HR2016-02-16
13F-HR2015-11-16
13F-HR2015-08-14
13F-HR2015-05-15
13F-HR2015-02-17
13F-HR2014-11-14
13F-HR2014-08-14

View March Altus Capital Management LP's complete filings history.

Compare quarters

Export March Altus Capital Management LP's holdings